RT Journal Article
SR Electronic
T1 Antibody responses to SARS-CoV-2 in COVID-19 patients: the perspective application of serological tests in clinical practice
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.03.18.20038018
DO 10.1101/2020.03.18.20038018
A1 Long, Quan-xin
A1 Deng, Hai-jun
A1 Chen, Juan
A1 Hu, Jie-li
A1 Liu, Bei-zhong
A1 Liao, Pu
A1 Lin, Yong
A1 Yu, Li-hua
A1 Mo, Zhan
A1 Xu, Yin-yin
A1 Gong, Fang
A1 Wu, Gui-cheng
A1 Zhang, Xian-xiang
A1 Chen, Yao-kai
A1 Li, Zhi-jie
A1 Wang, Kun
A1 Zhang, Xiao-li
A1 Tian, Wen-guang
A1 Niu, Chang-chun
A1 Yang, Qing-jun
A1 Xiang, Jiang-lin
A1 Du, Hong-xin
A1 Liu, Hua-wen
A1 Lang, Chun-hui
A1 Luo, Xiao-He
A1 Wu, Shao-bo
A1 Cui, Xiao-ping
A1 Zhou, Zheng
A1 Wang, Jing
A1 Xue, Cheng-jun
A1 Li, Xiao-feng
A1 Wang, Li
A1 Tang, Xiao-jun
A1 Zhang, Yong
A1 Qiu, Jing-fu
A1 Liu, Xia-mao
A1 Li, Jin-jing
A1 Zhang, De-chun
A1 Zhang, Fan
A1 Cai, Xue-fei
A1 Wang, De-qiang
A1 Hu, Yuan
A1 Ren, Ji-hua
A1 Tang, Ni
A1 Liu, Ping
A1 Li, Qin
A1 Huang, Ai-long
YR 2020
UL http://medrxiv.org/content/early/2020/03/20/2020.03.18.20038018.abstract
AB Background We aim to investigate the profile of acute antibody response in COVID-19 patients, and provide proposals for the usage of antibody test in clinical practice.Methods A multi-center cross-section study (285 patients) and a single-center follow-up study (63 patients) were performed to investigate the feature of acute antibody response to SARS-CoV-2. A cohort of 52 COVID-19 suspects and 64 close contacts were enrolled to evaluate the potentiality of the antibody test.Results The positive rate for IgG reached 100% around 20 days after symptoms onset. The median day of seroconversion for both lgG and IgM was 13 days after symptoms onset. Seroconversion of IgM occurred at the same time, or earlier, or later than that of IgG. IgG levels in 100% patients (19/19) entered a platform within 6 days after seroconversion. The criteria of ‘IgG seroconversion’ and ‘> 4-fold increase in the IgG titers in sequential samples’ together diagnosed 82.9% (34/41) of the patients. Antibody test aided to confirm 4 patients with COVID-19 from 52 suspects who failed to be confirmed by RT-PCR and 7 patients from 148 close contacts with negative RT-PCR.Conclusion IgM and IgG should be detected simultaneously at the early phase of infection. The serological diagnosis criterion of seroconversion or the ‘>; 4-fold increase in the IgG titer’ is suitable for a majority of COVID-19 patients. Serologic test is helpful for the diagnosis of SARS-CoV-2 infection in suspects and close contacts.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Emergency Project from the Science & Technology Commission of Chongqing; The Major National S&T program grant (2017ZX10202203 and 2017ZX10302201) from Science & Technology Commission of China; The grant (81871635, 81671997 and 81902060) from the National Natural Science Foundation of China, and the grant (20180141 and 20170413) from the Science & Technology Commission of Yuzhong district, Chongqing.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData referred to in the manuscript are available.